Green Cross to produce local tuberculosis vaccine

Published: 2010-05-07 06:57:00

Updated: 2010-05-07 06:57:00

Green Cross, one of the nation's biggest pharmaceutical companies, said it will start production of its tuberculosis vaccine in 2014, which will be backed by the Korean government.

To this end, the company held a ground-breaking ceremony on April 30 to construct a new tuberculosis vaccine plan...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK